Insmed (INSM) Other Non Operating Income (2013 - 2026)
Insmed (INSM) recorded quarterly Other Non Operating Income of -$736000.0 in Q1 2026, down 262.47% quarter-over-quarter from $453000.0 in Q2 2025, and down 657.58% on a YoY basis from $132000.0 in Q1 2025.
Insmed (INSM) Other Non Operating Income (2013 - 2026) Analysis & Trends
Insmed's Other Non Operating Income history runs 14 years deep, the most recent figure standing at -$736000.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income fell 657.58% year-over-year to -$736000.0; the TTM figure through Mar 2026 stood at -$283000.0 (up 90.93% YoY), while the FY2024 annual figure was -$236000.0, down 173.75% from the prior year.
- Other Non Operating Income was -$736000.0 for Q1 2026 at Insmed, down from $453000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $2.4 million in Q1 2024 to a low of -$3.9 million in Q3 2024.
- Historically, Other Non Operating Income has averaged -$437833.3 across 5 years, with a median of -$378500.0 in 2023.
- The sharpest annual moves came in 2025 and 2026: Other Non Operating Income surged 268.4% in 2025, then tumbled 657.58% in 2026.
- A 5-year view of Other Non Operating Income shows it stood at -$1.5 million in 2022, then surged by 141.55% to $634000.0 in 2023, then jumped by 37.22% to $870000.0 in 2024, then tumbled by 47.93% to $453000.0 in 2025, then plunged by 262.47% to -$736000.0 in 2026.
- The last three Other Non Operating Income figures came in at -$736000.0 (Q1 2026), $453000.0 (Q2 2025), and $132000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Insmed | 19.79 Bn | 18.57 Bn | 258.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -736,000.00 |
| Jun 30, 2025 | 453,000.00 |
| Mar 31, 2025 | 132,000.00 |
| Dec 31, 2024 | 870,000.00 |
| Sep 30, 2024 | -3.85 Mn |
| Jun 30, 2024 | -269,000.00 |
| Mar 31, 2024 | 2.36 Mn |
| Dec 31, 2023 | 634,000.00 |
| Sep 30, 2023 | -1.30 Mn |
| Jun 30, 2023 | -488,000.00 |
| Mar 31, 2023 | -1.53 Mn |
| Dec 31, 2022 | -1.53 Mn |
| Dec 31, 2021 | -2.65 Mn |
| Jun 30, 2021 | -17.69 Mn |
| Mar 31, 2021 | -43,000.00 |
| Dec 31, 2020 | 405,000.00 |
| Sep 30, 2020 | -4,000.00 |
| Mar 31, 2020 | 36,000.00 |
| Dec 31, 2019 | -276,000.00 |
| Sep 30, 2019 | -85,000.00 |